Skip to content

Clinical trials

Metabolic Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20101
20131
20143
20152
20182
20201
20212
20223
20231
20245
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting6
Active, not recruiting3
Not yet recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
89bio, Inc.2
Biolexis Therapeutics2
Calcilytix Therapeutics, Inc., a BridgeBio company2
Mondelēz International, Inc.2
4D Molecular Therapeutics1
Alexion Pharmaceuticals, Inc.1
Amgen1
AstraZeneca1
CRISPR Therapeutics AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases27
Glucose Metabolism Disorders8
Diabetes Mellitus, Type 27
Endocrine System Diseases6
Diabetes Mellitus5
Genetic Diseases, Inborn5
Lipid Metabolism Disorders4
Cardiovascular Diseases3
Central Nervous System Diseases3
Digestive System Diseases3

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.